$2.45T
Total marketcap
$90.22B
Total volume
BTC 50.48%     ETH 15.23%
Dominance

Stryker Corporation SYK.DE Stock

210.6 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
XETRA
Market Cap
79.57B EUR
LOW - HIGH [24H]
210.05 - 213.55 EUR
VOLUME [24H]
244 EUR
{{ volume }}
P/E Ratio
38.50
Earnings per share
5.47 EUR

Stryker Corporation Price Chart

Stryker Corporation SYK.DE Financial and Trading Overview

Stryker Corporation stock price 210.6 EUR
Previous Close 210.6 EUR
Open 210.05 EUR
Bid 0 EUR x N/A
Ask 0 EUR x N/A
Day's Range 210.05 - 213.55 EUR
52 Week Range 182.32 - 256.15 EUR
Volume 244 EUR
Avg. Volume 222 EUR
Market Cap 79.57B EUR
Beta (5Y Monthly) 0.960512
PE Ratio (TTM) 38.500916
EPS (TTM) 5.47 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

SYK.DE Valuation Measures

Enterprise Value 91.94B EUR
Trailing P/E 38.500916
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.0898185
Price/Book (mrq) 4.606904
Enterprise Value/Revenue 4.726
Enterprise Value/EBITDA 19.178

Trading Information

Stryker Corporation Stock Price History

Beta (5Y Monthly) 0.960512
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 256.15 EUR
52 Week Low 182.32 EUR
50-Day Moving Average 211.27 EUR
200-Day Moving Average 220.36 EUR

SYK.DE Share Statistics

Avg. Volume (3 month) 222 EUR
Avg. Daily Volume (10-Days) 85 EUR
Shares Outstanding 378.32M
Float 339.15M
Short Ratio N/A
% Held by Insiders 6.46%
% Held by Institutions 80.32%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.945
Trailing Annual Dividend Yield 1.39%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) June 30, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 13.92%
Operating Margin (ttm) 19.40%
Gross Margin 63.07%
EBITDA Margin 24.64%

Management Effectiveness

Return on Assets (ttm) 6.42%
Return on Equity (ttm) 16.40%

Income Statement

Revenue (ttm) 19.46B EUR
Revenue Per Share (ttm) 51.35 EUR
Quarterly Revenue Growth (yoy) 11.20%
Gross Profit (ttm) 11.65B EUR
EBITDA 4.79B EUR
Net Income Avi to Common (ttm) 2.71B EUR
Diluted EPS (ttm) 5.47
Quarterly Earnings Growth (yoy) 12.50%

Balance Sheet

Total Cash (mrq) 1.48B EUR
Total Cash Per Share (mrq) 3.89 EUR
Total Debt (mrq) 13.43B EUR
Total Debt/Equity (mrq) 77.39 EUR
Current Ratio (mrq) 1.542
Book Value Per Share (mrq) 45.714

Cash Flow Statement

Operating Cash Flow (ttm) 3.02B EUR
Levered Free Cash Flow (ttm) 2.12B EUR

Profile of Stryker Corporation

Country Germany
State MI
City Kalamazoo
Address 2825 Airview Boulevard
ZIP 49002
Phone 269 385 2600
Website https://www.stryker.com
Industry Medical Appliances & Equipment
Sector(s) Healthcare
Full Time Employees 51000

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Q&A For Stryker Corporation Stock

What is a current SYK.DE stock price?

Stryker Corporation SYK.DE stock price today per share is 210.6 EUR.

How to purchase Stryker Corporation stock?

You can buy SYK.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Stryker Corporation?

The stock symbol or ticker of Stryker Corporation is SYK.DE.

Which industry does the Stryker Corporation company belong to?

The Stryker Corporation industry is Medical Appliances & Equipment.

How many shares does Stryker Corporation have in circulation?

The max supply of Stryker Corporation shares is 377.81M.

What is Stryker Corporation Price to Earnings Ratio (PE Ratio)?

Stryker Corporation PE Ratio is 38.50091600 now.

What was Stryker Corporation earnings per share over the trailing 12 months (TTM)?

Stryker Corporation EPS is 5.47 EUR over the trailing 12 months.

Which sector does the Stryker Corporation company belong to?

The Stryker Corporation sector is Healthcare.